Purchases and Sales Made in Q2 2023 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q2 2023. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
32.8KNew |
$27.5K - $46.8K
|
32.8K
$1.59M
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.02K+ 423.56% |
$2.54K - $4.32K
|
3.73K
$181K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 6.45% |
$1.68 - $2.86
|
33
$1.6K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-800- 0.8% |
$672 - $1.14K
|
99.2K
$4.81M
|